Symbol Name # of Studies
FRA7E fragile site, aphidicolin type, common, fra(7)(q21.2) 0
FRA7F fragile site, aphidicolin type, common, fra(7)(q22) 0
FRA7G fragile site, aphidicolin type, common, fra(7)(q31.2) 0
FRA7H fragile site, aphidicolin type, common, fra(7)(q32.3) 0
FRA7I fragile site, aphidicolin type, common, fra(7)(q36) 0
FRA7J fragile site, aphidicolin type, common, fra(7)(q11) 0
FRA8A fragile site, folic acid type, rare, fra(8)(q22.3) 0
FRA8B fragile site, aphidicolin type, common, fra(8)(q22.1) 0
FRA8C fragile site, aphidicolin type, common, fra(8)(q24.1) 0
FRA8D fragile site, aphidicolin type, common, fra(8)(q24.3) 0
FRA8E fragile site, distamycin A type, rare, fra(8)(q24.1) 0
FRA9A fragile site, folic acid type, rare, fra(9)(p21) 0
FRA9B fragile site, folic acid type, rare, fra(9)(q32) 0
FRA9C fragile site, BrdU type, common, fra(9)(p21) 0
FRA9D fragile site, aphidicolin type, common, fra(9)(q22.1) 0
FRA9E fragile site, aphidicolin type, common, fra(9)(q32) 0
FRA9F fragile site, 5-azacytidine type, common, fra(9)(q12) 0
FRAS1-AS1 FRAS1 antisense RNA 1 0
FRAT1 FRAT regulator of Wnt signaling pathway 1 0
FRAT2 FRAT regulator of Wnt signaling pathway 2 0
FRAXA fragile site, folic acid type, rare, fra(X)(q27.3) A 0
FRAXB fragile site, aphidicolin type, common, fra(X)(p22.31) B 0
FRAXC fragile site, aphidicolin type, common, fra(X)(q22.1) C 0
FRAXD fragile site, aphidicolin type, common, fra(X)(q27.2) D 0
FRAXE fragile site, folic acid type, rare, fra(X)(q28) E 0